Nature Publishes Preclinical Characterization and Primate Efficacy Data on Junshi Biosciences' COVID-19 Neutralizing Antibodies
- Written by ACN Newswire
SHANGHAI, CHINA, May 27, 2020 - (ACN Newswire) - Junshi Biosciences (HKEX: 1877) a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, today announced the publication of research results from the company's efforts to generate therapeutic COVID-19 neutralizing...